Stéphane SUPIOT
Prof. Stéphane Supiot is a clinician Scientist in the Department of Radiation Oncology at Institut de Cancérologie de l’Ouest, University of Nantes, France. Prof. Supiot’s interests are in developmental therapeutics for pediatric and prostate cancer radiotherapy. His preclinical research interests are hypoxic response modifiers and the vascular response to irradiation. His clinical areas of research involve biochemically relapsing and oligometastatic prostate cancer. He is principal investigator on several clinical studies in the Groupe d’Etude des Tumeurs Uro Genitales-GETUG group, such as Oligopelvis GETUG P07, Oligopelvis 2 GETUG P12, POSTCARD GETUG P13, CARLHA GEP 12, CARLHA 2 GETUG 33.
Abstracts this author is presenting:
